The Friends of the AACR Foundation will honor Domenick Bucci, MD, as the Humanitarian Honoree and the HEADstrong Foundation...
In the final quarter of 2023, the FDA issued 17 approvals specifically for the treatment of tumors.
“What will you do Monday morning?” was the question posed by the final session on the final full day...
In 1994, at the age of 40, Ginny Mason, RN, began noticing some concerning differences in the size and...
In 2022, AACR launched a unique initiative called AACR Maximizing Opportunity for New Advancements in Research in Cancer (MONARCA)...
Studies featured at this year’s San Antonio Breast Cancer Symposium (SABCS) suggest that—in some situations—adjuvant radiotherapy may not be...
A breast cancer diagnosis can pose innumerable challenges, and with the average age at diagnosis dropping, the impact of...
Each December, an impressive cohort of breast cancer researchers gathers for the San Antonio Breast Cancer Symposium (SABCS), one...
As the deep reds and yellows of fall leaves give way to twinkling holiday lights, we welcome the new...
Ancient Greek physician Hippocrates considered the human body to be a system composed of four balanced fluids, or “humours.”...
With a five-year survival rate of only 12.5%, any progress toward new therapeutic approaches for pancreatic cancer is welcomed...